irinotecan has been researched along with Stroke in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Gofir, A; Hutajulu, SH; Nugroho, DB; Yuwono, KA | 1 |
| Fukunaga, M; Kaido, M; Kawabata, R; Kawase, T; Kimura, Y; Nakajima, Y; Ninomiya, H; Ohzato, H | 1 |
| Carpenter, W; Li, L; Meyerhardt, JA; Sanoff, HK; Schrag, D | 1 |
1 review(s) available for irinotecan and Stroke
| Article | Year |
|---|---|
Recurrent Reversible Stroke-Like Encephalopathy After 5-Fluorouracil (5-FU) Chemotherapy: A Case Report and Literature Review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cerebral Infarction; Colorectal Neoplasms; Fluorouracil; Humans; Infusions, Intravenous; Irinotecan; Stroke | 2023 |
2 other study(ies) available for irinotecan and Stroke
| Article | Year |
|---|---|
[Cases of three patients undergoing chemotherapy for gastric cancer who developed Trousseau's syndrome].
Topics: Adult; Aged; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Drug Combinations; Female; Humans; Irinotecan; Male; Middle Aged; Oxonic Acid; Stomach Neoplasms; Stroke; Tegafur | 2013 |
Effectiveness of bevacizumab with first-line combination chemotherapy for Medicare patients with stage IV colorectal cancer.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Cohort Studies; Colorectal Neoplasms; Comorbidity; Female; Humans; Intestinal Perforation; Irinotecan; Kaplan-Meier Estimate; Male; Medicare; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Stroke; Survival Rate; United States | 2012 |